|
|||||
|
|

Financial services company Equitable Holdings (NYSE:EQH) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 5.1% year on year to $3.80 billion. Its non-GAAP profit of $1.10 per share was 15.4% below analysts’ consensus estimates.
Is now the time to buy EQH? Find out in our full research report (it’s free).
Equitable Holdings’ second quarter results missed Wall Street’s estimates, with management attributing the shortfall primarily to elevated mortality claims within its Individual Life insurance block and softer fee-based earnings due to lower average equity market levels. CEO Mark Pearson described the quarter as impacted by “elevated individual life mortality claims,” while also noting progress on organic growth and strategic initiatives. The company pointed to robust net inflows in retirement and wealth management, as well as resilience in its asset management business, even as AllianceBernstein faced challenging industry conditions.
Looking ahead, Equitable Holdings’ forward guidance is anchored in the benefits expected from its recently completed Individual Life reinsurance transaction, reduced mortality exposure, and continued momentum in its core retirement and wealth management segments. Management anticipates that redeployment of freed capital and incremental share repurchases will support earnings per share growth in the second half of 2025. CFO Robin Raju noted, “EPS growth will certainly improve in the second half, and we’d expect to be back on track for the 12% to 15% [growth target] in 2026,” underscoring expectations for a return to targeted growth rates as strategic initiatives take effect.
Management attributed the quarter’s results to higher mortality claims, lower fee-based earnings, and continued execution on strategic capital initiatives, while highlighting organic growth in retirement and wealth management.
Equitable Holdings’ outlook is shaped by reduced earnings volatility from the reinsurance transaction, capital redeployment, and continued organic growth across its core businesses.
Looking forward, the StockStory team will be monitoring (1) the impact of the Individual Life reinsurance transaction on earnings volatility and cash flow, (2) the pace and effectiveness of share repurchases and capital deployment, and (3) continued organic growth in retirement and wealth management flows. Progress on expense management and execution of new product initiatives will also be key areas to watch.
Equitable Holdings currently trades at $53.08, up from $50.92 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
| Oct-29 | |
| Oct-28 | |
| Oct-27 | |
| Oct-27 | |
| Oct-21 | |
| Oct-20 | |
| Oct-14 | |
| Oct-09 | |
| Oct-09 | |
| Oct-08 | |
| Oct-07 | |
| Oct-06 | |
| Sep-23 | |
| Sep-15 | |
| Sep-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite